https://www.cochrane.org/de/evidence/CD009898_extracorporeal-photopheresis-treatment-chronic-graft-versus-host-disease-after-haematopoietic-stem
Extracorporeal photopheresis treatment for chronic graft-versus-host disease after haematopoietic...
graft versus host diseaseextracorporeal photopheresistreatment forchronic
https://www.mayo.edu/research/clinical-trials/cls-20548343
Extracorporeal Photopheresis And Mogamulizumab For The Treatment Of Erythrodermic Cutaneous T Cell...
Learn more about services at Mayo Clinic.
extracorporeal photopheresisfor the
https://www.rush.edu/treatments/extracorporeal-photopheresis
Extracorporeal Photopheresis | Rush
Extracorporeal photopheresis is an innovative treatment used to treat skin problems from cutaneous T-cell lymphoma (CTCL) and graft versus host disease.
extracorporeal photopheresisrush
https://pmc.ncbi.nlm.nih.gov/articles/PMC10838062/
Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease -...
Background: The mainstay first-line therapy for chronic graft-vs-host disease (cGVHD) is corticosteroids; however, for steroid-refractory patients, there is a...